Rogaratinib treatment of patients with advanced urothelial carcinomas prescreened for tumor FGFR mRNA expression.

被引：11

作者：

Joerger, Markus

Cassier, Philippe

Penel, Nicolas

Cathomas, Richard

Richly, Heike

Schostak, Martin

Janitzky, Andreas

Wermke, Martin

Nogova, Lucia

Tai, David Wai-Meng

Sayehli, Cyrus

Gruellich, Carsten

Grande, Enrique

Navarro, Alejandra

Park, Se Hoon

Gillessen, Silke

Nogai, Hendrik

Bender, Sebastian

Ellinghaus, Peter

Schuler, Martin H.

机构：

[1] Kantonsspital, St Gallen, Switzerland

[2] Ctr Leon Berard, Lyon, France

[3] Ctr Oscar Lambret, Lille, France

[4] Kantonsspital Graubuenden, Chur, Switzerland

[5] Univ Hosp Essen, W German Canc Ctr, Essen, Germany

[6] Otto Guericke Univ Magdeburg, Magdeburg, Germany

[7] Carl Gustav Carus Dresden Techn Univ Dresden, Dresden, Germany

[8] Univ Hosp Cologne, Cologne, Germany

[9] Natl Canc Ctr Singapore, Singapore, Singapore

[10] Univ Wurzburg, Wurzburg, Germany

[11] Heidelberg Univ, Heidelberg, Germany

[12] Ramon Cajal Univ Hosp, Madrid, Spain

[13] Vall Hebron Univ Hosp, Barcelona, Spain

[14] Sungkyunkwan Univ, Samsung Med Ctr, Seoul, South Korea

[15] Kantonsspital St Gallen, St Gallen, Switzerland

[16] Bayer AG, Berlin, Germany

[17] Bayer AG, Wuppertal, Germany

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 06期

关键词：

D O I：

10.1200/JCO.2018.36.6_suppl.494

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

494

引用

页数：1